Journal of Breast Cancer
Overview
The Journal of Breast Cancer is a peer-reviewed publication dedicated to advancing knowledge and understanding of breast cancer. It features original research articles, reviews, and case studies that cover various aspects of breast cancer, including prevention, diagnosis, treatment, and survivorship. The journal serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in breast cancer care and aims to contribute to the improvement of patient outcomes and quality of life.
Details
Details
Abbr.
J Breast Cancer
Start
2003
End
Continuing
Frequency
Bimonthly, 2020-
p-ISSN
1738-6756
e-ISSN
2092-9900
Country
South Korea
Languages
English
Korean
Korean
Metrics
Metrics
h-index / Ranks: 7562
48
SJR / Ranks: 6652
671
CiteScore / Ranks: 5670
4.60
JIF / Ranks: 4480
2.4
Recent Articles
1.
Letter to the Editor: "Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer"
Bergmann A, de Andrade M
J Breast Cancer
. 2025 Mar;
28(1):46-47.
PMID: 40047091
No abstract available.
2.
Byeon J, Kang E, Jung J, Cheun J, Seo K, Kim H, et al.
J Breast Cancer
. 2025 Mar;
28(1):48-49.
PMID: 40047090
No abstract available.
3.
Huang C, Tseng L
J Breast Cancer
. 2025 Mar;
28(1):37-45.
PMID: 40047089
Young female early breast cancer (≤ 40 years) treatment presents unique challenges due to its aggressive features. Using data from the Taiwan Cancer Registry (2007-2017), this study investigated its clinical...
4.
Zhang X, Yang C, Chen Y, Zhang J, Li P, Huang N, et al.
J Breast Cancer
. 2025 Mar;
28(1):23-36.
PMID: 40047088
Purpose: Human epidermal growth factor receptor 2 (HER2)-low breast cancer has the potential to emerge as a distinct subtype. Several studies have compared the differences between HER2-low and HER2-0 breast...
5.
Lee Y, Yoo T, Lee S, Chung I, Kim H, Ko B, et al.
J Breast Cancer
. 2025 Mar;
28(1):11-22.
PMID: 40047087
Purpose: This study analyzed the pathological complete response (pCR) rates, long-term outcomes, and biological features of human epidermal growth factor receptor 2 (HER2)-zero, HER2-low, and HER2-positive breast cancer patients undergoing...
6.
Lee C, Shin D, Kim K, Nam S, Kim S, Yu J, et al.
J Breast Cancer
. 2025 Mar;
28(1):1-10.
PMID: 40047086
Purpose: Breast cancer gene () mutation is a well-known risk factor for breast cancer, and clinical interest in prophylactic mastectomy has increased in recent years. We investigated patients who were...
7.
Moon S, Min K, Kim T, Um J, Kook Y, Baek S, et al.
J Breast Cancer
. 2025 Jan;
27(6):395-406.
PMID: 39761945
Capsular contracture (CC) is a concerning issue for individuals undergoing postmastectomy radiation therapy (PMRT) with implant-based breast reconstruction. This study investigated whether the extent of CC and implant migration differs...
8.
Sae-Lim C, Jo S, Park S, Kweon T, Lee J, Lee Y, et al.
J Breast Cancer
. 2025 Jan;
27(6):372-382.
PMID: 39761944
Purpose: The partner and localizer of breast cancer 2 (PALB2) mutation is a predisposition to breast cancer development. However, limited clinical data are available for the Korean population. Therefore, this...
9.
Rajadurai P, Yap N, Chiew S, Md Zin R, Md Pauzi S, Jaafar A, et al.
J Breast Cancer
. 2024 Dec;
27(6):362-371.
PMID: 39622509
Purpose: Triple-negative breast cancer (TNBC) is a subtype of breast cancer known for its poor prognosis and the absence of viable targets for standard receptor-based therapies. Several studies have suggested...
10.
Kim C, Jung Y, Jeong J, Kim H, Choi J, Suh Y, et al.
J Breast Cancer
. 2024 Dec;
27(6):383-394.
PMID: 39622508
By investigating the characteristics and prognosis of breast cancer (BC) patients who have undergone hormone replacement therapy (HRT), this study addresses a gap in the existing literature. A total of...